Fairman R P, Falls R, Millen J E, Glauser F L
Clin Toxicol. 1980 Mar;16(1):25-31. doi: 10.3109/15563658008989920.
The injection of ethchlorvynol intravenously in humans and animals causes an increased permeability form of pulmonary edema. The proximate cause for this increased alveolar capillary membrane permeability is unknown but humoral mediators such as histamine and prostaglandins could play a role. To determine whether these agents were a factor in the altered permeability, we employed the saline-filled dog lung model and measured the flux of albumin across the alveolar capillary membrane. Following the intravenous injection of ethchlorvynol, there was a marked increase in permeability which was not altered by treatment with H1 and H2 receptor blockers or a prostaglandin synthetase inhibitor. We conclude that histamine and prostaglandins play no role in the increased permeability associated with ethchlorvynol injection.
在人和动物身上静脉注射乙氯维诺会导致通透性增加型肺水肿。这种肺泡毛细血管膜通透性增加的直接原因尚不清楚,但组胺和前列腺素等体液介质可能起作用。为了确定这些介质是否是通透性改变的一个因素,我们采用了生理盐水灌注的狗肺模型,并测量了白蛋白通过肺泡毛细血管膜的通量。静脉注射乙氯维诺后,通透性显著增加,而用H1和H2受体阻滞剂或前列腺素合成酶抑制剂治疗并没有改变这种情况。我们得出结论,组胺和前列腺素在与乙氯维诺注射相关的通透性增加中不起作用。